Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kleine-Tebbe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Zentralblatt Fur Gynakologie|January 1, 1996
[Upright birthing position--more birth canal injuries? Results of a retrospective comparative study]A Kleine-Tebbe, M David, M Farkić
Allergy|May 20, 2003
Type I sensitization towards patent blue as a cause of anaphylaxisK Forschner, A Kleine-Tebbe, T Zuberbier, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 20, 2011
Increasing constipation and abdominal fullnessM Dewey, J Stockhaus, A Kleine-Tebbe, et al.
Acta Dermato-Venereologica|March 14, 1998
Multicentric reticulohistiocytosis indicating metastasis of an unknown primary tumourM Worm, A Kleine-Tebbe, E von Stebut, et al.
International Archives of Allergy and Immunology|January 1, 1993
Role of the major allergen (Fel d I) in patients sensitized to cat allergensJ Kleine-Tebbe, A Kleine-Tebbe, S Jeep, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2015
Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patientsV Kanti, R Nuwayhid, J Lindner, et al.
The British Journal of Dermatology|March 20, 2014
Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort studyV Kanti, R Nuwayhid, J Lindner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trialJ-U Blohmer, P Schmid, J Hilfrich, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2010
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trialM Kaufmann, N Maass, S D Costa, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Zentralblatt Fur Gynakologie|January 1, 1996
[Upright birthing position--more birth canal injuries? Results of a retrospective comparative study]A Kleine-Tebbe, M David, M Farkić
Allergy|May 20, 2003
Type I sensitization towards patent blue as a cause of anaphylaxisK Forschner, A Kleine-Tebbe, T Zuberbier, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 20, 2011
Increasing constipation and abdominal fullnessM Dewey, J Stockhaus, A Kleine-Tebbe, et al.
Acta Dermato-Venereologica|March 14, 1998
Multicentric reticulohistiocytosis indicating metastasis of an unknown primary tumourM Worm, A Kleine-Tebbe, E von Stebut, et al.
International Archives of Allergy and Immunology|January 1, 1993
Role of the major allergen (Fel d I) in patients sensitized to cat allergensJ Kleine-Tebbe, A Kleine-Tebbe, S Jeep, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2015
Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patientsV Kanti, R Nuwayhid, J Lindner, et al.
The British Journal of Dermatology|March 20, 2014
Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort studyV Kanti, R Nuwayhid, J Lindner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trialJ-U Blohmer, P Schmid, J Hilfrich, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2010
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trialM Kaufmann, N Maass, S D Costa, et al.
Pageof 1